The proposed biosimilar Pegfilgrastim is one of the six biologic products co-developed by Mylan and Biocon for the global marketplace, the two companies said in a statement.USFDA accepts Mylan's BLA for proposed biosimilar Pegfilgrastim
The proposed biosimilar Pegfilgrastim is one of the six biologic products co-developed by Mylan and Biocon for the global marketplace, the two companies said in a statement.
0 коммент.:
Отправить комментарий